Previous 10 | Next 10 |
home / stock / azncf / azncf news
AstraZeneca PLC (AZN) Q2 2021 Earnings Conference Call July 29, 2021 6:45 AM ET Company Participants Pascal Soriot - Executive Director and Chief Executive Officer Dave Fredrickson - EVP, Oncology Business Unit Ruud Dobber - EVP, BioPharmaceuticals Business Unit Marc Dunoyer - Executive Direc...
Fisher’s 13F portfolio value increased from ~$142B to ~$159B in Q2 2021. The Vanguard Intermediate-Term Corporate Bond ETF stake was increased substantially this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~14% of the portfolio. F...
The following slide deck was published by AstraZeneca PLC in conjunction with their 2021 Q2 earnings call. For further details see: AstraZeneca PLC 2021 Q2 - Results - Earnings Call Presentation
Zoom uses its expensive stock to enter adjacent market with the acquisition of Five9 for $14.7 billion. Monmouth Real Estate Investment Corporation's board supports the pending merger of MNR with Equity Commonwealth after receiving a competing offer from Starwood. Salesforce compl...
Moderna and Novavax are leading Biotech companies who are expected to be major competitors in the COVID-19 vaccine market moving forward. While Moderna has a strong head start in the market in 2021, Novavax's impending entry is likely to offer stiff competition. Both companies als...
Baker Brothers’ 13F portfolio value decreased from $26.54B to $23.07B this quarter. The large stake in Alexion Pharmaceuticals was decreased during the quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~57% of the portfol...
Healthcare, financials, and technology led the way in Q2. Energy, materials, industrials, and gold could have done better. With regards to Bitcoin and digital assets, I made a mistake. I made some adjustments for Q3 and expect to discuss more gains three months from now. ...
Insilico Medicine, a Hong Kong company devoted to using AI to speed up drug discovery and R&D, closed a $255 million Series C round led by Warburg Pincus. Jointech, a Hangzhou medical device company, has raised $62 million over the last 15 months to support its orthopedic surgery ...
AstraZeneca (OTCMKTS: AZNCF) and the European Union (EU) both claim to have won a legal battle in which the EU accused the pharmaceutical company of not producing enough vaccine doses at a satisfactory speed. The company had originally committed to ...
After years of brewing its medicine, Sesen is poised to gain FDA approval for Vicineum as a treatment for non-muscle-invasive bladder cancer. In the VISTA trial, Vicineum demonstrated robust efficacy which trumped all competing molecules. Epitomized as a run-up phenomenon, Sesen s...
News, Short Squeeze, Breakout and More Instantly...
Inaugural Asia Summit on Global Health successfully explores healthcare landscape HONG KONG, Nov 25, 2021 - (ACN Newswire) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural...
Inaugural Asia Summit on Global Health opens today HONG KONG, Nov 24, 2021 - (ACN Newswire) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (...
A new study with information regarding the “rare but devastating” blood clotting issue affiliated with the Oxford- AstraZeneca (OTCMKTS: AZNCF) Covid-19 vaccine has been released. Nevertheless, according to British scientists, there have been no new cases of blood cl...